Sialophorin is an essential host element for vaccine immunity against pulmonary fungal infections
Abstract
The global burden of fungal infections is alarming, primarily due to the increasing immune-compromised population. The immuno-preventive/therapeutic measures, including vaccines, are necessary to prevent or control fungal diseases. Identifying a protective host element as a functional phenotypic marker is immensely valuable. We identified a host element, sialophorin, preferentially associated with antifungal memory T cells. We investigated its role in vaccine immunity using a mouse model of pulmonary fungal infection. We found that sialophorin was essential to bolster CD8+ T-cell responses to the vaccine by enhancing their differentiation and expanding cytokine-producing cells required for immunity. Using a gain-of-function approach, activating sialophorin using mAb augmented the CD8+ T cell responses, and sialophorin-sufficient CD8+ T cells were competitively superior in differentiation and expansion to the deficient cells. Sialophorin-mediated vaccine immunity was independent of the T cell trafficking effect. Finally, we show that sialophorin is a potential functional phenotypic marker of fungal vaccine-potency and immunity. Our study revealed that sialophorin is an essential host-target element to bolster vaccine responses and serves as a potential biomarker of fungal immunity. Author SummaryFungal infections have been rising in recent years due to increased immunocompromised individuals. Vaccination of at-risk individuals helps counter the infections. Thus, suitable vaccine platforms are needed with apt adjuvants, and a phenotypic marker of vaccine immunity will bolster the efforts. We identified a phenotypic marker, sialophorin, associated with T cell vaccine immunity to fungal infection. Our findings show an essential role of sialophorin for fungal immunity, as a target of adjuvanticity, and as a potential biomarker of vaccine immunity against many fungal infections.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combination adjuvants enhance recombinant protein vaccine protection against fungal infection
M. Wuethrich, H. E. Dobson, … B. S. Klein·bioRxiv·Mar 11, 2021
- Combination adjuvants drive long lived plastic Th17 cells that convert to multi-functional Th1 cells and protect mice against fungal infection
Marcel Wüthrich, Uju Joy Okaa, … Bruce S. Klein·mBioPeer-reviewed·Jun 11, 2026
- Structural basis of Blastomyces Endoglucanase-2adjuvancy in anti-fungal and -viral immunity
L. Dos Santos Dias, H. E. Dobson, … M. Wuethrich·bioRxiv·Jun 24, 2020
- Improved humoral immunity and protection against influenza virus infection with a 3D porous biomaterial vaccine
H. Miwa, O. Q. Antao, … D. Di Carlo·bioRxiv·Dec 16, 2022
- Natural Killer Cell Granule Protein (NKG7) promotes the development of vaccine-induced anti-fungal Th1 cells
Marcel Wüthrich, Cleison Ledesma Taira, … Bruce S. Klein·bioRxiv·Apr 23, 2026
- MAIT cells activate dendritic cells to promote T follicular helper cell differentiation and humoral immunity
T. E. Pankhurst, K. H. Buick, … L. M. Connor·bioRxiv·Mar 31, 2022